Frontotemporal dementia patients with extrapyramidal symptoms have brainstem atrophy and reduced metabolism in certain areas of the brain significantly more often than patients without extrapyramidal ...

Depression with anxiety disorder started in summer of 2004. From 28/7/2004 to 22/11/2004 (4 months) the patient was taking Citalopram 20 mg per day and Alprazolam 0.5 mg three times per day. On ...

Erzofri is an atypical antipsychotic that is administered once a month as an intramuscular injection. The Food and Drug Administration (FDA) has approved Erzofri ® (paliperidone palmitate) ...

ATLANTA — Vraylar was generally safe, well-tolerated and effective in FDA-approved dose ranges among individuals with schizophrenia or bipolar I disorder, according to data presented at the American ...

The approval was supported by data from a 6-week, phase 3, double-blind, placebo-controlled, fixed-dose study that compared the efficacy and safety of Secuado 3.8mg/24 hours and 7.6mg/24 hours to ...

The approval of medicines called second-generation antipsychotics has allowed major depressive disorder (MDD) and other conditions linked to it to be treated. A person with MDD is usually prescribed ...